01 1Lupin Limited
02 1Lupin Ltd
01 1Daeshin Muyak Co., Ltd.
02 1IMCD Korea Co., Ltd.
01 2Lovastatin
01 2India
Registrant Name : IMCD Korea Co., Ltd.
Registration Date : 2005-12-13
Registration Number : 20051213-7-B-210-05
Manufacturer Name : Lupin Ltd
Manufacturer Address : T-142, MIDC Tarapur, Via Boisar Maharashtra 401 506
Registrant Name : Daeshin Muyak Co., Ltd.
Registration Date : 2011-08-12
Registration Number : 20051213-7-B-210-05(1)
Manufacturer Name : Lupin Limited
Manufacturer Address : T-142, MIDC Tarapur, Via Boisar, Maharashtra 401 506
57
PharmaCompass offers a list of Lovastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Lovastatin manufacturer or Lovastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lovastatin manufacturer or Lovastatin supplier.
A Rextat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rextat, including repackagers and relabelers. The FDA regulates Rextat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rextat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rextat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Rextat supplier is an individual or a company that provides Rextat active pharmaceutical ingredient (API) or Rextat finished formulations upon request. The Rextat suppliers may include Rextat API manufacturers, exporters, distributors and traders.
click here to find a list of Rextat suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rextat Drug Master File in Korea (Rextat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rextat. The MFDS reviews the Rextat KDMF as part of the drug registration process and uses the information provided in the Rextat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rextat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rextat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rextat suppliers with KDMF on PharmaCompass.
